All identified cancer cell lines express SHP2 and certain diffuse gastric cancer (DGC) cell lines with MET or fibroblast growth factor receptor 2 (FGFR2) gene amplification exhibit preferential tyrosine phosphorylation. The gene discussed is PTPN11; the disease is cancer.